Urogen Pharma LtdNASDAQ:URGN
- LAST PRICE16.1000
- TODAY'S CHANGE (%)0.2200 (1.3854%)
- Bid / Lots14.8500/ 1
- Ask / Lots16.5000/ 3
- Open / Previous Close15.9800 / 15.8800
- Day Range
- 52 Week Range
- Volume357,529
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | URGN |
|---|---|---|
| 09:32 ET | 7525 | 16.054 |
| 09:34 ET | 700 | 16.08 |
| 09:36 ET | 2700 | 16.085 |
| 09:38 ET | 400 | 16.23 |
| 09:39 ET | 100 | 15.97 |
| 09:41 ET | 2800 | 16.19 |
| 09:43 ET | 2707 | 16.055 |
| 09:45 ET | 1487 | 15.94 |
| 09:48 ET | 400 | 16.015 |
| 09:50 ET | 2000 | 15.91 |
| 09:52 ET | 858 | 15.91 |
| 09:54 ET | 200 | 15.93 |
| 09:56 ET | 456 | 15.91 |
| 09:57 ET | 900 | 15.965 |
| 09:59 ET | 900 | 16.15 |
| 10:01 ET | 100 | 16.15 |
| 10:03 ET | 688 | 16.07 |
| 10:06 ET | 2400 | 16.2 |
| 10:08 ET | 1240 | 16.205 |
| 10:10 ET | 263 | 16.25 |
| 10:12 ET | 200 | 16.205 |
| 10:14 ET | 1400 | 16.205 |
| 10:15 ET | 1852 | 16.205 |
| 10:17 ET | 700 | 16.18 |
| 10:19 ET | 500 | 16.205 |
| 10:21 ET | 1000 | 16.205 |
| 10:24 ET | 6711 | 16.2 |
| 10:26 ET | 17547 | 16.35 |
| 10:28 ET | 1537 | 16.36 |
| 10:30 ET | 2979 | 16.3 |
| 10:32 ET | 577 | 16.27 |
| 10:33 ET | 390 | 16.29 |
| 10:35 ET | 100 | 16.28 |
| 10:37 ET | 800 | 16.28 |
| 10:39 ET | 2400 | 16.365 |
| 10:42 ET | 2650 | 16.4 |
| 10:44 ET | 1421 | 16.4 |
| 10:46 ET | 800 | 16.399 |
| 10:48 ET | 5403 | 16.4 |
| 10:50 ET | 1766 | 16.41 |
| 10:51 ET | 2527 | 16.38 |
| 10:53 ET | 4746 | 16.4 |
| 10:55 ET | 1300 | 16.36 |
| 10:57 ET | 399 | 16.38 |
| 11:02 ET | 9784 | 16.36 |
| 11:04 ET | 676 | 16.335 |
| 11:06 ET | 2580 | 16.23 |
| 11:08 ET | 561 | 16.23 |
| 11:09 ET | 100 | 16.23 |
| 11:15 ET | 515 | 16.24 |
| 11:18 ET | 872 | 16.1818 |
| 11:24 ET | 100 | 16.19 |
| 11:26 ET | 200 | 16.23 |
| 11:27 ET | 3400 | 16.19 |
| 11:31 ET | 1500 | 16.18 |
| 11:33 ET | 5040 | 16.175 |
| 11:36 ET | 100 | 16.17 |
| 11:40 ET | 191 | 16.12 |
| 11:44 ET | 1000 | 16.07 |
| 11:45 ET | 1220 | 16.06 |
| 11:49 ET | 100 | 16.04 |
| 11:51 ET | 700 | 16.03 |
| 11:54 ET | 100 | 16.01 |
| 11:58 ET | 400 | 16 |
| 12:00 ET | 100 | 16 |
| 12:02 ET | 200 | 16 |
| 12:03 ET | 300 | 16.01 |
| 12:05 ET | 300 | 15.95 |
| 12:09 ET | 1600 | 16.025 |
| 12:16 ET | 2370 | 16.01 |
| 12:20 ET | 300 | 15.97 |
| 12:21 ET | 200 | 16.0091 |
| 12:23 ET | 200 | 16.02 |
| 12:25 ET | 200 | 16.02 |
| 12:27 ET | 100 | 15.99 |
| 12:30 ET | 600 | 15.98 |
| 12:32 ET | 600 | 16 |
| 12:34 ET | 200 | 15.99 |
| 12:36 ET | 100 | 16.03 |
| 12:38 ET | 100 | 16.02 |
| 12:39 ET | 221 | 16.04 |
| 12:41 ET | 100 | 16.02 |
| 12:43 ET | 1024 | 16.06 |
| 12:45 ET | 100 | 16.05 |
| 12:48 ET | 200 | 16.065 |
| 12:52 ET | 300 | 16.1 |
| 12:57 ET | 525 | 16.08 |
| 12:59 ET | 1336 | 16.06 |
| 01:01 ET | 100 | 16.06 |
| 01:03 ET | 2200 | 16.16 |
| 01:08 ET | 100 | 16.22 |
| 01:10 ET | 300 | 16.195 |
| 01:14 ET | 200 | 16.195 |
| 01:15 ET | 2676 | 16.09 |
| 01:17 ET | 100 | 16.105 |
| 01:19 ET | 100 | 16.07 |
| 01:21 ET | 200 | 16.095 |
| 01:24 ET | 354 | 16.095 |
| 01:28 ET | 100 | 16.07 |
| 01:30 ET | 100 | 16.07 |
| 01:32 ET | 1421 | 16.135 |
| 01:37 ET | 252 | 16.12 |
| 01:39 ET | 100 | 16.135 |
| 01:42 ET | 100 | 16.135 |
| 01:50 ET | 100 | 16.1 |
| 01:51 ET | 1217 | 16.09 |
| 01:55 ET | 100 | 16.091 |
| 01:57 ET | 4433 | 16 |
| 02:00 ET | 100 | 16.04 |
| 02:02 ET | 514 | 16.045 |
| 02:04 ET | 1156 | 16.105 |
| 02:08 ET | 1000 | 16.1 |
| 02:09 ET | 200 | 16.1 |
| 02:11 ET | 200 | 16.1 |
| 02:18 ET | 500 | 16.11 |
| 02:24 ET | 100 | 16.11 |
| 02:27 ET | 575 | 16.09 |
| 02:31 ET | 800 | 16.09 |
| 02:33 ET | 777 | 16.1 |
| 02:36 ET | 300 | 16.105 |
| 02:38 ET | 1111 | 16.085 |
| 02:40 ET | 200 | 16.08 |
| 02:42 ET | 400 | 16.06 |
| 02:47 ET | 100 | 15.98 |
| 02:49 ET | 400 | 15.95 |
| 02:51 ET | 1202 | 15.98 |
| 02:56 ET | 420 | 15.98 |
| 02:58 ET | 669 | 15.99 |
| 03:00 ET | 1000 | 15.96 |
| 03:02 ET | 300 | 15.965 |
| 03:03 ET | 300 | 15.97 |
| 03:09 ET | 510 | 15.98 |
| 03:12 ET | 1475 | 15.95 |
| 03:14 ET | 300 | 15.95 |
| 03:16 ET | 200 | 15.95 |
| 03:18 ET | 470 | 15.95 |
| 03:20 ET | 200 | 15.96 |
| 03:21 ET | 210 | 15.97 |
| 03:23 ET | 1645 | 15.98 |
| 03:25 ET | 100 | 15.96 |
| 03:27 ET | 200 | 15.975 |
| 03:30 ET | 1715 | 15.95 |
| 03:32 ET | 2500 | 15.98 |
| 03:34 ET | 1937 | 16.03 |
| 03:36 ET | 100 | 16.038 |
| 03:38 ET | 918 | 16.05 |
| 03:39 ET | 500 | 16.08 |
| 03:41 ET | 1503 | 16.04 |
| 03:43 ET | 1208 | 16.04 |
| 03:45 ET | 700 | 16.03 |
| 03:48 ET | 431 | 16.03 |
| 03:50 ET | 3884 | 16.04 |
| 03:52 ET | 786 | 16.05 |
| 03:54 ET | 3935 | 16.05 |
| 03:56 ET | 9168 | 16.1 |
| 03:57 ET | 10884 | 16.095 |
| 03:59 ET | 55314 | 16.1 |
Jul 1, 2024
DJ UroGen Pharma Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:05AM ET on Monday Jul 01, 2024 by Dow Jones
7:05AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 17, 2024
*DJ UroGen Pharma Prices Public Offering of Shares, Prefunded Warrants >URGN, from 10:53PM ET on Monday Jun 17, 2024 by Dow Jones
10:53PM ET on Monday Jun 17, 2024 by Dow JonesUroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants, from 10:51PM ET on Monday Jun 17, 2024 by Dow Jones
10:51PM ET on Monday Jun 17, 2024 by Dow JonesUroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants, from 4:46PM ET on Monday Jun 17, 2024 by Dow Jones
4:46PM ET on Monday Jun 17, 2024 by Dow Jones
Jun 14, 2024
DJ UroGen Pharma Is Maintained at Buy by Ladenburg Thalmann, from 2:51PM ET on Friday Jun 14, 2024 by Dow Jones
2:51PM ET on Friday Jun 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Urogen Pharma Ltd | 653.8M | -4.7x | --- |
SAGE Therapeutics Inc | 648.8M | -1.3x | --- |
Zymeworks Inc | 627.9M | -5.0x | --- |
Regenxbio Inc | 536.9M | -1.8x | --- |
Y-mAbs Therapeutics Inc | 500.3M | -22.8x | --- |
WAVE Life Sciences Ltd | 669.9M | -10.6x | --- |
Company Information
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).
Contact Information
- Headquarters
- 9 Ha'ta'asiya StRA'ANANA, Israel 4365007
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Arie Belldegrun
- President, Chief Executive Officer, Director
- Elizabeth Barrett
- Chief Financial Officer
- Dong Kim
- Chief Compliance Officer, General Counsel, Corporate Secretary
- Jason Smith
- Chief Commercial Officer
- David Lin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $653.8M |
|---|---|
Revenue (TTM) | $84.3M |
Shares Outstanding | 41.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.12 |
EPS | $-3.39 |
Book Value | $-2.01 |
P/E Ratio | -4.7x |
Price/Sales (TTM) | 7.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -82.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
